Ibaraki, Japan

Keiko Ota

This inventor holds 2 USPTO granted patents. Top assignee: Agency of Industrial Science and Technology. Active years: 2006-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Keiko Ota. Retrieved from https://idiyas.com/inventor/keiko-ota-maeaig0s

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2006-2007

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Keiko Ota: Innovator in Heparin-Binding Proteins

Introduction

Keiko Ota is a prominent inventor based in Ibaraki, Japan. She has made significant contributions to the field of biochemistry, particularly in the development of heparin-binding proteins. With a total of 2 patents, her work has implications for pharmaceutical compositions and protein functionalization.

Latest Patents

Ota's latest patents focus on heparin-binding proteins modified with sugar chains. These patents describe a heparin-binding protein that is functionalized by covalently bonding a sugar chain to it. The patents also detail a method for producing this protein and a pharmaceutical composition that contains it as an active ingredient. Additionally, she has developed a method for functionalizing a natural protein that lacks a sugar chain by covalently bonding a sugar chain to it.

Career Highlights

Throughout her career, Keiko Ota has held significant positions, including Director-General of the Agency of Industrial Science and Technology. Her leadership in this role has contributed to advancements in industrial science and technology in Japan.

Collaborations

Ota has collaborated with notable colleagues such as Toru Imamura and Masahiro Asada. These partnerships have likely enriched her research and development efforts in the field.

Conclusion

Keiko Ota's innovative work in heparin-binding proteins and her leadership in industrial science highlight her as a key figure in biochemistry. Her contributions continue to influence the development of pharmaceutical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…